Neurosurgery News and Research RSS Feed - Neurosurgery News and Research

Research evidence supports use of deep brain stimulation for OCD patients

Research evidence supports use of deep brain stimulation for OCD patients

Available research evidence supports the use of deep brain stimulation (DBS) for patients with obsessive-compulsive disorder (OCD) who don't respond to other treatments, concludes a review in the October issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. [More]
Sanovas announces commercialization of MicroCam System via Healthmark Industries

Sanovas announces commercialization of MicroCam System via Healthmark Industries

Sanovas Inc., a Life Science company accelerating the development and commercialization of next-generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that its MicroCam Inc. subsidiary has commenced commercialization of the MicroCam System via its OEM partnership with Healthmark Industries, which is launching its new product—Flexible Inspection Scope—this week. [More]
Olympus signs agreement with Brainlab to become exclusive U.S. distributor of Kick Navigation

Olympus signs agreement with Brainlab to become exclusive U.S. distributor of Kick Navigation

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today it has reached a deal with Munich-based Brainlab to be the exclusive U.S. distributor of Kick Navigation. [More]
Vercise DBS System receives CE Mark approval for treatment of essential tremor

Vercise DBS System receives CE Mark approval for treatment of essential tremor

Boston Scientific Corporation has received CE Mark for the Vercise Deep Brain Stimulation (DBS) System for the treatment of tremor, including the most common form of this movement disorder known as essential tremor (ET). [More]
AANS, ASTRO partner to launch national registry for SRS treatments

AANS, ASTRO partner to launch national registry for SRS treatments

The American Association of Neurological Surgeons and the American Society for Radiation Oncology are partnering to launch and support a national registry for stereotactic radiosurgery (SRS) treatments. [More]
WellStar establishes new health park in East Cobb

WellStar establishes new health park in East Cobb

WellStar East Cobb Health Park opened its doors September 15, serving as a comprehensive, one-stop shop for outpatient medical needs. [More]
Broach Foundation makes $5 million commitment to support glioblastoma multiforme research

Broach Foundation makes $5 million commitment to support glioblastoma multiforme research

The Broach Foundation for Brain Cancer Research has made a $5 million commitment to support glioblastoma multiforme research at The University of Texas MD Anderson Cancer Center. [More]
Study: High-dose prescribing increases by 23% in Canada

Study: High-dose prescribing increases by 23% in Canada

High-dose opioid prescribing increased by 23 per cent in Canada between 2006 and 2011, despite clinical guidelines recommending that most patients should avoid high-doses of these drugs, according to new research. [More]
Neurologists implant neurostimulator in brain to control seizures

Neurologists implant neurostimulator in brain to control seizures

It has been 30 days since neurologists at the University of Alabama at Birmingham turned on the neurostimulator implanted in Sarah Conner's brain to control her seizures. [More]
Most prevalent form of discrimination is due to mental illness and homelessness

Most prevalent form of discrimination is due to mental illness and homelessness

Vulnerable populations in ethnically diverse Toronto reported more discrimination by health care workers based on their housing status, mental health or substance abuse issues than race, a new study has found. [More]
Codman reaches exclusive distribution agreement with Pulsar Vascular to market PulseRider

Codman reaches exclusive distribution agreement with Pulsar Vascular to market PulseRider

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, today announced it has reached an exclusive distribution agreement with Pulsar Vascular to market and promote that company's PulseRider® in Europe, the Middle East and Africa. [More]
One-two punch designed to knock out most dangerous brain cancer

One-two punch designed to knock out most dangerous brain cancer

University of Michigan Health System doctors have started testing a unique new approach to fighting brain tumors -- one that delivers a one-two punch designed to knock out the most dangerous brain cancer. [More]
Vasopressin more effective for cardiopulmonary resuscitation

Vasopressin more effective for cardiopulmonary resuscitation

Epinephrine has been shown to be a first-choice drug for cardiopulmonary resuscitation. Nevertheless, its β-adrenergic effect probably increases myocardial oxygen consumption and leads to severe cardiac and cerebral injuries; moreover, epinephrine does not elevate long-term survival rates. [More]
Study: Young athletes need to avoid continuous repetitive activity to decrease risk of pars fracture

Study: Young athletes need to avoid continuous repetitive activity to decrease risk of pars fracture

Young athletes today often participate in sports year round and with increasingly competitive club and school sports, it has become common to choose one sport to specialize at a young age. While this specialization may seem like a competitive edge, new Northwestern Medicine research suggests that repetitive activity in just one sport, high impact or not, may not be a great idea for growing athletes. [More]
Sequent Medical initiates patient enrollment in IDE pivotal trial of WEB Aneurysm Embolization System

Sequent Medical initiates patient enrollment in IDE pivotal trial of WEB Aneurysm Embolization System

Sequent Medical, Inc. announced today that it has initiated patient enrollment in an Investigational Device Exemption ("IDE") pivotal trial to evaluate the safety and effectiveness of the WEB Aneurysm Embolization System ("WEB"). [More]
Receiving prescription at discharge improves outcomes in stroke patients

Receiving prescription at discharge improves outcomes in stroke patients

Stroke patients are 70 per cent more likely to continue taking their stroke prevention medications one year later if they have a prescription in hand when discharged - according to researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences. [More]
Use of VISIUS iMRI in brain tumor surgery results in complete tumor removal

Use of VISIUS iMRI in brain tumor surgery results in complete tumor removal

IMRIS Inc. today announced that a recently published article in the journal Neurosurgery is the highest level clinical evidence to show that the use of VISIUS® intraoperative MRI in brain tumor surgery results in complete tumor removal in more patients with glioma tumors. [More]
Researchers find why certain glioblastomas become drug resistance

Researchers find why certain glioblastomas become drug resistance

Researchers at the University of California, San Diego School of Medicine have found one of the keys to why certain glioblastomas - the primary form of a deadly brain cancer - are resistant to drug therapy. [More]
Injections of anaerobic bacteria can shrink tumors in rats, dogs and human

Injections of anaerobic bacteria can shrink tumors in rats, dogs and human

Deep within most tumors lie areas that remain untouched by chemotherapy and radiation. These troublesome spots lack the blood and oxygen needed for traditional therapies to work, but provide the perfect target for a new cancer treatment using bacteria that thrive in oxygen-poor conditions. [More]

Andrews Institute performs free injury evaluations for student athletes

Student athletes will soon have access to free injury evaluations by an orthopaedic physician on Saturdays at the Andrews Institute for Orthopaedics & Sports Medicine. [More]